News Conference News EHRA 2019 High-Dose Nifedipine Tied to Higher Cardiac Arrest Risk Todd Neale March 18, 2019
News Daily News High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin Shelley Wood March 08, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
Presentation JIM 2019 Consider Low Dose RIVAROXABAN + SAPT Presenter: Roxana Mehran February 15, 2019
Presentation JIM 2019 Clinical case: Management of long-term antithrombotic therapy Presenter: Giuseppe Tarantini February 15, 2019
Presentation JIM 2019 Log-linear association per unit change in LDL-C and the risk of CV disease-a statin tale Presenter: Bernardo Cortese February 15, 2019
Presentation JIM 2019 GP IIb/IIIa inhibitors are still the best option Presenter: Alberto Menozzi February 15, 2019
Presentation ISC 2019 Treatment of Factor Xa Inhibitor-Associated Bleeding with Andexanet Alfa: Full Results of ANNEXA-4 Presenter: Stuart J. Connolly February 08, 2019
News Daily News Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests Michael O'Riordan February 08, 2019
News Daily News Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests Todd Neale February 01, 2019
News Daily News Bias Over Knowledge: Whether Patients Get Guideline-Recommended Statins Depends on Physician Beliefs Yael L. Maxwell January 10, 2019
News Daily News Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests L.A. McKeown January 08, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2018 Caitlin E. Cox January 01, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2018 Shelley Wood November 30, 2018
News Daily News Certain Risk Factors Carry Higher MI Risk in Women Than in Men Shelley Wood November 23, 2018
News Conference News AHA 2018 EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018